CymaBay Therapeutics Slumps: CBAY Falls 18.5% in Session - Tale of the Tape
CymaBay Therapeutics Inc. (CBAY) saw a big move last session, as the company’s shares fell by nearly 19% on the day. The move came on pretty good volume too with far more shares changing hands than in a normal session. This reverses the recent trend for CBAY as the stock is now up by nearly 2% since Jan 28.
The company has seen a flat track record when it comes to current year estimate revisions over the past few weeks (0 increases, 0 decreases), and the consensus for earnings hasn’t been in a trend either. This recent price action is discouraging, so make sure to keep a close watch on this firm in the near future, and especially on earnings estimates following the recent slump.
CBAY currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.
A better-ranked stock in the medical sector is Affymetrix Inc. (AFFX), holding a Zacks Rank #2 (Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
CYMABAY THERAPT (CBAY): Free Stock Analysis Report
AFFYMETRIX INC (AFFX): Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
